Q4 2014 Holdings
Filed 2015-02-11 | 23 holdings | $146.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Universal American Corp. | COM | 91338E101 | $27.8K | 3,000,000 | 19.1% |
| Orexigen Therapeutics, Inc. | COM | 686164104 | $24.3K | 4,017,666 | 16.7% |
| Zafgen, Inc. | COM | 98885E103 | $15.4K | 500,166 | 10.6% |
| Auspex Pharmaceuticals, Inc. | COM | 05211J102 | $9.0K | 171,824 | 6.2% |
| Alder Biopharmaceuticals Inc. | COM | 14339105 | $7.1K | 245,000 | 4.9% |
| Scynexis, Inc. | COM | 811292101 | $6.6K | 662,945 | 4.5% |
| Aerie Pharmaceuticals, Inc.(AERIEUR) | COM | 00771V108 | $6.4K | 220,067 | 4.4% |
| Quotient Limited | SHS | G73268107 | $5.9K | 327,631 | 4.0% |
| Sage Therapeutics, Inc.(SG7) | COM | 78667J108 | $5.3K | 144,569 | 3.6% |
| Juno Therapeutics Inc. | COM | 48205A109 | $4.8K | 91,575 | 3.3% |
| BioDelivery Sciences International, Inc.(BDSIUSD) | COM | 09060J106 | $4.7K | 393,683 | 3.2% |
| T2 Biosystems, Inc. | COM | 89853L104 | $4.4K | 228,421 | 3.0% |
| Epizyme, Inc.(EPZMEUR) | COM | 29428V104 | $3.8K | 201,806 | 2.6% |
| ProQR Therapeutics N.V. | SHS EURO | N71542109 | $3.8K | 173,067 | 2.6% |
| Anacor Pharmaceuticals, Inc. | COM | 32420101 | $3.4K | 106,849 | 2.4% |
| Agile Therapeutics, Inc.(AGRXUSD) | COM | 00847L100 | $3.3K | 534,882 | 2.2% |
| Bellicum Pharmaceuticals, Inc. | COM | 79481107 | $2.4K | 105,000 | 1.7% |
| BioDelivery Sciences International, Inc.(BDSIUSD)Call | COM | 09060J106 | $2.0K | 170,000 | 1.4% |
| Ignyta, Inc. | COM | 451731103 | $1.9K | 275,000 | 1.3% |
| Orexigen Therapeutics, Inc.Call | COM | 686164104 | $1.5K | 251,500 | 1.0% |
| BioDelivery Sciences International, Inc.(BDSIUSD)Put | COM | 09060J106 | $1.2K | 100,000 | 0.8% |
| Orexigen Therapeutics, Inc.Put | COM | 686164104 | $606 | 100,000 | 0.4% |
| Amedica Corporation | COM | 23435100 | $180 | 225,000 | 0.1% |